By expenditures
| Name | Title | Type |
|---|---|---|
| Randy Scollins | FINANCE DIRECTOR | Auditee |
| Paul Gargano | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 348819 | 2024 | 2025-03-27 | Roselli Clark and Associates | $6.81M |
| 8590 | 2023 | 2023-12-27 | Roselli Clark & Associates | $4.69M |
| 43491 | 2022 | 2023-01-17 | Roselli Clark & Associates | $4.79M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 8590 | 2023 | 2023-12-27 | 583088 | 2023-003 | - | - | B |
| 8590 | 2023 | 2023-12-27 | 583087 | 2023-003 | - | - | B |
| 8590 | 2023 | 2023-12-27 | 583086 | 2023-003 | - | - | B |
| 8590 | 2023 | 2023-12-27 | 583085 | 2023-003 | - | - | B |
| 8590 | 2023 | 2023-12-27 | 583084 | 2023-003 | - | - | B |
| 8590 | 2023 | 2023-12-27 | 583083 | 2023-003 | - | - | B |
| 8590 | 2023 | 2023-12-27 | 583082 | 2023-002 | Significant Deficiency | - | I |
| 8590 | 2023 | 2023-12-27 | 583081 | 2023-002 | Significant Deficiency | - | I |
| 8590 | 2023 | 2023-12-27 | 583080 | 2023-002 | Significant Deficiency | - | I |
| 8590 | 2023 | 2023-12-27 | 583079 | 2023-002 | Significant Deficiency | - | I |
| 8590 | 2023 | 2023-12-27 | 583078 | 2023-002 | Significant Deficiency | - | I |
| 8590 | 2023 | 2023-12-27 | 583077 | 2023-002 | Significant Deficiency | - | I |
| 8590 | 2023 | 2023-12-27 | 583076 | 2023-001 | Material Weakness | - | I |
| 8590 | 2023 | 2023-12-27 | 583075 | 2023-001 | Material Weakness | - | I |
| 8590 | 2023 | 2023-12-27 | 583074 | 2023-001 | Material Weakness | - | I |
| 8590 | 2023 | 2023-12-27 | 583073 | 2023-001 | Material Weakness | - | I |
| 8590 | 2023 | 2023-12-27 | 583072 | 2023-001 | Material Weakness | - | I |
| 8590 | 2023 | 2023-12-27 | 583071 | 2023-001 | Material Weakness | - | I |
| 8590 | 2023 | 2023-12-27 | 6646 | 2023-003 | - | - | B |
| 8590 | 2023 | 2023-12-27 | 6645 | 2023-003 | - | - | B |
| 8590 | 2023 | 2023-12-27 | 6644 | 2023-003 | - | - | B |
| 8590 | 2023 | 2023-12-27 | 6643 | 2023-003 | - | - | B |
| 8590 | 2023 | 2023-12-27 | 6642 | 2023-003 | - | - | B |
| 8590 | 2023 | 2023-12-27 | 6641 | 2023-003 | - | - | B |
| 8590 | 2023 | 2023-12-27 | 6640 | 2023-002 | Significant Deficiency | - | I |
| 8590 | 2023 | 2023-12-27 | 6639 | 2023-002 | Significant Deficiency | - | I |
| 8590 | 2023 | 2023-12-27 | 6638 | 2023-002 | Significant Deficiency | - | I |
| 8590 | 2023 | 2023-12-27 | 6637 | 2023-002 | Significant Deficiency | - | I |
| 8590 | 2023 | 2023-12-27 | 6636 | 2023-002 | Significant Deficiency | - | I |
| 8590 | 2023 | 2023-12-27 | 6635 | 2023-002 | Significant Deficiency | - | I |
| 8590 | 2023 | 2023-12-27 | 6634 | 2023-001 | Material Weakness | - | I |
| 8590 | 2023 | 2023-12-27 | 6633 | 2023-001 | Material Weakness | - | I |
| 8590 | 2023 | 2023-12-27 | 6632 | 2023-001 | Material Weakness | - | I |
| 8590 | 2023 | 2023-12-27 | 6631 | 2023-001 | Material Weakness | - | I |
| 8590 | 2023 | 2023-12-27 | 6630 | 2023-001 | Material Weakness | - | I |
| 8590 | 2023 | 2023-12-27 | 6629 | 2023-001 | Material Weakness | - | I |